Home

arrow iconNewsarrow iconarrow icon

INVO Fertility, Inc. Announces WFI Clinic Joined the Progyny Network to Expand Patient Access

INVO Fertility, Inc. Announces WFI Clinic Joined the Progyny Network to Expand Patient Access

INVO Fertility, Inc has confirmed that its Wisconsin Fertility Institute-WFI clinic joined the Progyny network, making advanced reproductive care more widely available and accessible for more patients seeking fertility treatment.

By FertilityIn

12 Oct 2026

1 min read

Invo Logo

Invo Logo

INVO Fertility, Inc., a fertility company that seeks to make advanced reproductive care more available by opening, buying, and running fertility clinics and related businesses and technologies, says that its Wisconsin Fertility Institute-WFI clinic joined the Progyny network.


Progyny offers fertility and family-building advantages to about 7.2 million people through more than 600 employers and plan sponsors across the country. WFI's potential market in Wisconsin and the neighbouring areas is bigger now that it is part of the Progyny network. This arrangement makes it much easier for the clinic to visit patients whose companies cover them.


Patients who meet the requirements can now get all of WFI's reproductive services, including diagnostic testing, in vitro fertilisation (IVF), fertility preservation, and other advanced treatment options, all through their network. Progyny's scientifically integrated benefit design makes it easier for patients to keep track of their money and paperwork. The program decreases barriers to care and helps people use therapy more effectively and receive better results. Progyny is a big part of the fertility business because it helps patients with the two biggest problems they have: getting care and paying for it.


As the WFI clinic joined the Progyny network, it improved its mix of third-party payers from a business point of view and lets it help more people who require care. As more and more companies offer reproductive benefits, it is becoming more and more necessary to work with the best fertility benefits administrators to promote organic growth.


Employer-sponsored fertility benefits are one of the fastest-growing parts of healthcare benefits. Companies want to hire and keep the best workers, so they offer these benefits. INVO Reproductive believes that making its services easier to find on well-known national benefit platforms will help it stay competitive and assist its increasing network of reproductive centres to grow even further. The company sees the move as a big step forward and an important part of its overall plan to grow its clinic platform, build stronger relationships with payers, and improve its long-term financial performance.


According to COO of INVO Fertility, April McGhee, “We are excited to join the Progyny network, a leader in fertility benefits known for its commitment to transparency, exceptional client and member satisfaction, and superior clinical outcomes." This partnership expands access to high-quality fertility treatment for more patients while reinforcing our focus on delivering exceptional results and a seamless, supportive care experience. We look forward to helping Progyny members build their families with confidence.”


Steve Shum, CEO of INVO Fertility, says that “This relationship expands our addressable patient base and strengthens our access to employer-sponsored demand." “As we continue to grow through strategic clinic development and acquisitions, establishing relationships with leading benefits providers like Progyny represents a further enhancement to our growth objectives, operating leverage, and ability to drive long-term value creation for our shareholders.”

72 views

Share

FertilityIn

Send Enquiry for this Story

Related Articles

Fertility Treatment Coverage Gap Revealed by Stork Foundation

Fertility Treatment Coverage Gap Revealed by Stork Foundation

The Stork Foundation for Infertility received a record 1,076 grant applications in 2026, with data revealing that 85% of applicants have no fertility treatment coverage for the care they are pursuing. Average anticipated next treatment costs stand at 19,149 USD, with 39% having already spent more than 10,000 USD out of pocket.

ART

1 min read

Future Health Abu Dhabi Opens Digital Health Innovation Challenge 2026

Future Health Abu Dhabi Opens Digital Health Innovation Challenge 2026

Future Health, A Global Initiative by Abu Dhabi has launched the Future Health Digital Health Innovation Challenge 2026, inviting global innovators to develop AI, software, and connected technology solutions across fertility, population health, and well-being. Three finalists will share USD 105,000 at GITEX 2026, with selected solutions eligible for incubation and scale.

ART

1 min read

La Trobe University and GonGlobal Partner to Advance AI-Driven Fertility Care Through Digital Twin Technology

La Trobe University and GonGlobal Partner to Advance AI-Driven Fertility Care Through Digital Twin Technology

La Trobe University and GonGlobal have entered a strategic collaboration to develop and validate AI and digital twin technologies for ART and IVF. The partnership will build AI-driven fertility care tools, including cohort matching digital twins and deep-learning models, to predict pregnancy outcomes and support personalised clinical decision-making.

ART

1 min read

The World Egg and Sperm Bank Joins IVI Institute to Widen Access to Reproductive Solutions Globally

The World Egg and Sperm Bank Joins IVI Institute to Widen Access to Reproductive Solutions Globally

IVI Institute has announced the acquisition of The World Egg and Sperm Bank (TWESB), founded in 2004 and operating from Scottsdale, Arizona. The move expands access to reproductive solutions for patients and clinics across the United States and Australia, combining TWESB’s network of 500+ screened donors with IVI Institute’s global clinical and scientific infrastructure.

ART

1 min read

UK’s First Testicular Tissue Transplant Offers Hope for Fertility Preservation

UK’s First Testicular Tissue Transplant Offers Hope for Fertility Preservation

Doctors at NHS Lothian in Edinburgh have performed the UK’s first testicular tissue transplant, reimplanting tissue frozen before chemotherapy in a 19-year-old patient with a serious blood disorder. The testicular tissue transplant, only the second reported worldwide, could eventually give thousands of young boys a realistic path to future fatherhood.

ART

1 min read

AiVA AI Assistant: IVI RMA Launches Fertility AI Platform

AiVA AI Assistant: IVI RMA Launches Fertility AI Platform

Flora Fertility and Clue have announced the Flora Clue fertility partnership, connecting the first individually owned fertility insurance platform with the world’s leading women-led cycle tracking app. FLORA policyholders receive complimentary Clue Plus access, while Clue’s community of over 100 million members gains early exposure to proactive fertility financial planning.

ART

1 min read

WHO Issues First Global Guideline on Infertility Care

WHO Issues First Global Guideline on Infertility Care

The World Health Organization releases its first comprehensive, evidence-based global guideline for infertility prevention, diagnosis, and treatment. Addressing one in six people of reproductive age worldwide, the guideline emphasizes equity, human rights, and standardized interventions to improve access to fertility care globally.

ART

1 min read

Landing Page Image

Subscribe to our Newsletter

Stay updated with the latest news, expert insights, and exclusive offers delivered straight to your inbox. Join our community today!

Email Address